Leritrelvir
Pharmaceutical compound
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Nº Q132528726 ★★
Uncommon · Knowledge
Leritrelvir
Pharmaceutical compound
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Text: Wikipédia, CC BY-SA 4.0. · Image: User:Innerstream (Public domain) ·
Related cards
-
Ensitrelvir
Chemical compound
Nº Q110798570 ★★
Not listed
-
Simnotrelvir/ritonavir
Antiviral combination medication
Nº Q122877522 ★★★
Not listed
-
I
Ingavirin
Chemical compound
Nº Q21659121 ★★★
Not listed
-
Ritonavir
Chemical compound
Nº Q422618 ★★★
Not listed
-
P
Protease inhibitor (pharmacology)
Class of antiviral drugs used to treat HIV/AIDS and hepatitis C
Nº Q55761529 ★
Not listed
-
Nirmatrelvir/ritonavir
Antiviral combination medication
Nº Q110442458 ★
Not listed